SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Co-CEO Helmy Eltoukhy sold $9.4 million of company stock, a transaction that is minor relative to both the company's market capitalization and the insider's total holdings.
• Market Impact: Neutral. The sale is unlikely to influence market sentiment due to its small relative size.

Company Information

Field	Value
Company	Guardant Health, Inc.
Ticker Symbol	GH
CIK	0001576280
Industry	Services-Medical Laboratories

Insider Information

Field	Value
Name	Eltoukhy Helmy
CIK	0001752968
Title/Position	Co-Chief Executive Officer
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-15
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	90,565
Price Per Share	$103.81 (Weighted Avg.)
Total Value	$9,401,312
Shares Owned After	2,047,143
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$9,401,312
% of Market Cap	0.077%
Shares Transacted	90,565
% of Shares Outstanding	Not Available
Post-Transaction Ownership	2,047,143 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The $9.4 million sale is negligible when compared to Guardant Health's $12.26 billion market capitalization, representing just 0.077% of the company's value. This is well below the threshold for a transaction to be considered significant.
• Ownership Concentration: The sale of 90,565 shares constitutes approximately 4.2% of the insider's prior holdings. This is not a substantial reduction and does not suggest a significant loss of confidence in the company's prospects. It is more indicative of a routine diversification or liquidity event for the executive.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: A sale of this size from a C-level executive is routine and does not provide a strong signal to the market. The value is insignificant relative to the company's large-cap status.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transaction is not large enough to materially affect trading volume.
• Sentiment Indicator: Neutral. The market is unlikely to interpret this small, partial sale by a long-term insider as a bearish signal.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates the shares were sold in multiple transactions at weighted average prices. There is no mention of this sale being conducted under a pre-arranged 10b5-1 trading plan.